8-K//Current report
Spyre Therapeutics, Inc. 8-K
Accession 0001636282-25-000091
$SYRECIK 0001636282operating
Filed
Aug 4, 8:00 PM ET
Accepted
Aug 5, 4:09 PM ET
Size
362.8 KB
Accession
0001636282-25-000091
Documents
- 8-Ksyre-20250805.htmPrimary
8-K
- EX-99.1spyre-20250630xexx991.htm
EX-99.1
- EX-101.SCHsyre-20250805.xsd
XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT
- EX-101.LABsyre-20250805_lab.xml
XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT
- EX-101.PREsyre-20250805_pre.xml
XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT
- GRAPHICspyre-logoxhorizontalxfull.jpg
GRAPHIC
- XMLR1.htm
IDEA: XBRL DOCUMENT
- XMLShow.js
IDEA: XBRL DOCUMENT
- XMLreport.css
IDEA: XBRL DOCUMENT
- XMLFilingSummary.xml
IDEA: XBRL DOCUMENT
- JSONMetaLinks.json
IDEA: XBRL DOCUMENT
- ZIP0001636282-25-000091-xbrl.zip
IDEA: XBRL DOCUMENT
- XMLsyre-20250805_htm.xml
IDEA: XBRL DOCUMENT
Issuer
Spyre Therapeutics, Inc.
CIK 0001636282
Entity typeoperating
IncorporatedDE
Related Parties
1- filerCIK 0001636282
Filing Metadata
- Form type
- 8-K
- Filed
- Aug 4, 8:00 PM ET
- Accepted
- Aug 5, 4:09 PM ET
- Size
- 362.8 KB